The following is FutureSearch's forecast for Anthropic's financial and technological path through May 2027. My central case has ARR reaching $93B by May 2027 (p10 $58B, p90 $149B), with Claude Code contributing about $21B, and the IPO pricing around December 15, 2026.
June changed the risk picture more than the central numbers. Anthropic brought its Mythos-class tier to general availability on June 9 as Fable 5 and Mythos 5, the first public models above the Opus line. Three days later a Commerce Department export-control order forced both offline worldwide, and they were still down on June 17. The suspension stretched the delay and downside tails on almost every forecast here while leaving the commercial core close to where it was. I work through the financial fallout from that one event in a companion piece on how the Fable ban changes Anthropic's IPO and valuation.
The distributions anchor to the Series H close at $965B post-money (Crunchbase), the $47B run-rate disclosure that came with it, the June 1 confidential S-1 filing (Anthropic) that started the listing clock, and the June 9 launch and June 12 suspension of the Mythos-class tier (Anthropic). OpenAI joined the listing race with its own June 8 filing. For the head-to-head, see Anthropic and OpenAI IPO dates and valuations.
At the $965B Series H mark, Anthropic trades at about 21x current ARR and 10x my median 2027 ARR. I expect the public market to price it at or above that mark. My median for the 90-day post-IPO market cap is $1.09 trillion.
Anthropic disclosed $47 billion in run-rate revenue as of mid-May 2026, per the May 28 Series H announcement (Anthropic). That is the anchor for the trajectory above. CFO Krishna Rao's number extends Dario Amodei's earlier walk ($9B Dec 2025, $14B Feb, $19B March, $30B April, $44B early May) and lines up with the Q2 2026 GAAP projection of $10.9B in quarterly revenue that Anthropic shared with Series H investors (CNBC). The company is adding about $96M in annualized revenue per day.
The p50 of $93B by May 2027 (p10 $58B, p90 $149B) assumes that pace decelerates in absolute terms while it keeps compounding. Three structural drivers support it: enterprise concentration (1,000+ customers spending $1M+ annually, up from 500 in February per Sacra), the coding moat (54% of coding-specific LLM spend per Menlo), and cross-cloud distribution no competitor has matched.
Claude Code is the live ammunition. It went from $500M ARR in September 2025 to $8B in May 2026, and the p50 of $21B by May 2027 (p10 $11.5B, p90 $42B) assumes the doubling-every-six-weeks cadence settles to roughly 2.5x annual. The case for the right tail is that agentic workloads consume 10 to 100 times more compute per developer-day than chat, and Anthropic owns the coding category. Opus 4.8's launch theme reinforces it, centered on Dynamic Workflows that orchestrate hundreds of parallel subagents and run codebase-scale migrations from kickoff to merge.
Cursor is the live counter. It launched its own model in November 2025 and is now near $4B ARR with a 60% enterprise mix (MLQ), double where it sat at launch. The disintermediation risk is real, and I no longer wave it off. What the June suspension showed is the other side of the ledger: Claude Code runs on the Opus and Sonnet lines, which the export order left untouched, so the category's revenue base kept compounding through the same shock that pulled the flagship offline.
The single biggest tail risk on the revenue line is the gross-revenue accounting question. Anthropic books cloud-reseller end-customer spend on a gross basis (Sacra), so full customer spend hits revenue and partner payouts hit expenses. A forced restatement to net during IPO due diligence would cut headline ARR by 20 to 40% in one print. I think that risk is real but overstated. Stripe books gross. Shopify books gross. The cloud-reseller relationship is the genuine customer-of-record arrangement, not a flow-through, and I put the auditor risk in the single digits rather than the 20-30% the $400-500B public-market targets imply.
The 20x weekly Sonnet hour cap is the most-watched consumer proxy for whether Anthropic has compute headroom. The line stepped from 240 hours in 2024 to 360 through most of 2025, then jumped three times in five weeks in early May (Medium), all following the SpaceX/xAI deal that lifted Opus API limits more than 1500% (Anthropic). That looked like the constraint breaking.
The Series H announcement complicates the picture. Anthropic "has struggled to meet demand in recent months, forcing it to institute usage limits during peak hours and incentivize off-peak use" (Reuters). Anthropic is managing the rationing. It has not cleared it. The forecast sits at a p50 of 593 hours (p10 320, p90 1,333). The May +50% boost expires July 13, and I treat most of it as semi-permanent rather than a one-off.
Pricing tells the sharper story. The Mythos-class tier shipped at $50 per million output tokens ($10 input), double the $25 Opus anchor that held across four consecutive generations, 4.5 through 4.8. With availability now uncertain after the suspension, my forecast for the top GA model's output price in May 2027 is bimodal: about $50 in the roughly 85% of outcomes where a Mythos-class model is generally available, with a roughly 15% Opus-only tail at $25. The p50 is $50 and the p90 is $65. For comparison, GPT-5.5 sits at $30 and Gemini 3.1 Pro at $12, so even at $50 Anthropic is pricing on capability rather than rationing demand through price.
Capacity is arriving. Anthropic announced fresh commitments alongside the Series H: AWS expansion of up to 5GW, Google and Broadcom for 5GW of TPUs, and SpaceX access to Colossus 1 and 2. Strategic memory and storage suppliers (Micron, Samsung, SK hynix) joined the equity round, an unusual signal of long-term supply preference. Demand is absorbing it faster than the May evidence alone suggested.
On June 9, Anthropic brought Mythos-class to general availability as Fable 5 and Mythos 5, the first public tier above the Opus line. Fable 5 posts 95.0% on SWE-bench Verified and 80.3% on the harder SWE-bench Pro (Axios). That delivered on the roadmap split Anthropic signaled in late May, positioning Mythos-class as a premium tier above incremental Opus 4.x releases rather than as a single model branded "Claude 5."
SWE-bench Verified is saturated, so the live frontier metric is now SWE-bench Pro. My forecast for the top GA model's Pro score by May 2027 is a p50 of 88.2% (p10 77%, p90 95%). The lower tail reflects the worlds where a Mythos-class model stays restricted and the Opus line carries the frontier; the median reflects a restored Mythos-class tier climbing from Fable 5's 80.3% start.
The June 12 suspension is the swing factor. A Commerce Department "Is Informed" letter under the Export Control Reform Act, with foreign-national scope, forced Anthropic to disable Fable 5 and Mythos 5 worldwide, and both were still down on June 17. I forecast restoration at a median of July 22, 2026 (p10 in late June, p90 January 31, 2027). That question has since resolved. The US lifted the export controls and Fable and Mythos returned on July 1, 2026, graded against the original call on the Fable forecast page. That July 22 figure is the June 18 view. The companion page refined the restoration median to July 9 in its June 23 update, against an actual July 1. I put the probability that a Mythos-class model is available and unsuspended on May 21, 2027 at 85%. The full walk-through of how the suspension moves the financials is in the companion piece.
The ASL-4 question softened. Anthropic's RSP v3 moved away from a binary ASL-4 line, and the security-readiness target is July 1, 2027, just past this window, which lowers the incentive to make an early determination. I put the probability of an ASL-4-equivalent determination by May 2027 at 38%.
One cadence note. Opus 4.8 shipped 41 days after 4.7, the fastest flagship gap in Anthropic's history, while Sonnet and Haiku are months stale. Anthropic is concentrating on the Opus flagship cadence and the Mythos-class track and letting the mid and low tiers ride. The next generational jump ships as a Mythos-class release, not as a model called "Claude 5."
Anthropic filed a confidential draft S-1 on June 1, 2026. That resolved the open Series H question, whether the round was a substitute for an IPO or a bridge to one, in favor of bridge. The investor list is the cleanest evidence: Capital Group co-led, with Fidelity and T. Rowe Price participating. Mutual funds pay $965B for early access to a listing they expect above that mark, not for a long-term private position.
The procedural calendar pulls the median earlier and the tail later. Confidential SEC review for a company of Anthropic's scale runs three to six months, then a public flip, a 15-day cooling period, a one to two week roadshow, and pricing. SpaceX ran about 11 weeks confidential to pricing; Reddit ran nine months on multiple comment rounds. Anthropic carries three friction factors: gross-vs-net accounting, the item reviewers spend the most time on; the Department of War litigation, which needs material risk-factor disclosure; and now the export action, a fresh risk factor that puts the government's demonstrated ability to switch off the flagship into the S-1.
The distribution lands at p10 September 28, 2026, p25 November 2, p50 December 15, p75 April 1, 2027, and p90 April 1, 2028. The median sits inside the window, but the right tail runs a full year longer than it did before June 12, and the probability of pricing before May 21, 2027 is about 78%, down from the high-80s I had before the export action.
Update (July 1, 2026). Commerce lifted the export order on June 30 and Fable 5 and Mythos 5 returned worldwide on July 1. Re-running this forecast after the lift pulls the IPO median toward November 2026, a few weeks earlier than the pre-lift December view, and compresses the far tail from April 2028 back into 2027 as the export overhang moves from active to historical. The downside 90-day valuation recovers from about $627B toward $720B while the median holds near $1.1T, so roughly half to three-quarters of the ban's damage unwinds. The distribution above and the valuation percentiles below are the June 18 pre-lift baseline, kept as written. The full before-and-after is in the companion piece on how the Fable ban changes Anthropic's IPO and valuation.
Valuation is the more important number. SpaceX priced its IPO at $1.77T and traded above $2T on its debut, the cleanest mega-cap comp on the board (see our SpaceX valuation). My median for Anthropic's 90-day post-IPO market cap is $1.09 trillion (p10 $627B, p90 $1.84T). The export overhang and the gross-accounting question widen the downside; the SpaceX comp and pure-play frontier-AI appetite widen the upside. At $1.09T against $93B of forward ARR, the public market prices Anthropic at about 12x forward revenue, a modest premium to the Series H, and the mutual funds that anchored that round are pricing the median outcome rather than chasing the bull case.
The Department of War designated Anthropic a supply-chain risk on March 3-4 under 10 U.S.C. § 3252 and FASCSA. Judge Rita Lin granted a preliminary injunction on March 26 (CNN); the D.C. Circuit denied an emergency stay on April 8; oral arguments ran May 19, where Judge Henderson called the designation "spectacular overreach" and Judge Katsas pressed Anthropic on its shifting usage policies (Axios). The panel ran skeptical of the government, and the ruling is under advisement. Secretary Hegseth doubled down on the designation on June 4.
The June 12 export action is a sharper lever than the procurement designation. It hit the product itself, where the procurement designation only ever touched the contracts. That is what makes the federal track a live input to this forecast, no longer the sideshow I treated it as in the spring.
The relationship is two-sided. The NSA carved Mythos-class out for its own use (Axios, April 19; FT, June 5, reporting roughly six embedded engineers). The intelligence community wants the product even as Commerce and the Pentagon fight it. That two-sidedness is why I put a $100M+ DoD or IC prime contract by May 2027 at 20%, up from near zero in the spring, on the strength of the NSA relationship, though classified awards rarely surface a public figure. I put the supply-chain designation vacated by May 2027 at 31%, given the skeptical panel, tempered by the strict bar for vacatur and the likely appeals.
None of this changes the revenue base by more than a few percent. Anthropic is on pace for $93B ARR without federal procurement, where a $100M contract rounds to noise. What changed in June is the disclosure surface and the tail risk, not the trajectory.
The three scenarios come out at decoupling with friction 48%, convergence 30%, and entanglement 22%.
Decoupling with friction is the base case. Commercial and intelligence-community trajectories proceed, punctuated by federal disruptions with the Fable suspension as the template. ARR lands $85-105B, a Mythos-class model returns under a US-person compliance regime, and the IPO prices between late 2026 and early 2027.
Convergence is the bull case. Federal détente meets a capability bull: a Mythos-class model fully restored, the designation vacated, an IC prime contract surfaces, and the IPO prices clean above $1.3T.
Entanglement is the bear case, and it is heavier than it was in the spring. Federal friction institutionalizes, a Mythos-class model stays stuck in a restricted or permanent-control regime, the IPO slips into late 2027 or 2028, and accounting or litigation overhang bites.
Six predictions I would take the over on, given those scenarios.
Anthropic prices its IPO above $1T between November 2026 and March 2027. The confidential S-1 is in, the Series H mutual-fund anchor is the price floor, and OpenAI's parallel filing adds competitive pressure. Probability: 60%.
A Mythos-class model is back in general availability before the end of 2026. The restoration median is late July, and the impasse would have to harden into a permanent-control regime to push past year-end. Probability: 80%.
The top GA model holds its $50 output price rather than reverting to the $25 Opus anchor. The Mythos-class tier set the new ceiling, and Anthropic prices on capability. Probability: 70%.
ARR ends 2026 between $75B and $90B, and the May 2027 print lands at or above $95B. The $47B May starting point plus agentic expansion plus a restored premium tier supports the high end. Probability: 50%.
The 90-day post-IPO market cap clears $1T. The SpaceX comp, the Series H floor, and frontier-AI appetite align. Probability: 70%.
No $100M+ DoD or IC prime contract surfaces publicly before May 2027, even as the NSA relationship deepens. Classified awards stay opaque, and the procurement designation stays on the books. Probability: 80%.
Pulling it together: at $965B Anthropic trades at 21x current ARR and 10x my median 2027 ARR. The commercial case the public-market skeptics underrated is intact, with ARR near $93B, Claude Code compounding on compute the suspension never touched, and a flagship that saturated SWE-bench Verified. June added a risk the old bull case left out. The government showed it can switch the flagship off, and that shows up in fatter IPO-delay and valuation-downside tails rather than in the central numbers. I would still buy Anthropic at $965B. I would hedge the federal tail.
Run this forecast yourself by connecting FutureSearch to Claude. Then ask Claude to refresh the numbers any time the news cycle moves.